RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PEDRAZZOLI P
Collezione AOU San Luigi di Orbassano

Items : 6

Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers. in Applied clinical informatics / Appl Clin Inform. 2024 Aug;15(4):743-750. doi: 10.1055/s-0044-1788331. Epub 2024 Sep 11.

2024
AOU San Luigi di Orbassano

Albiñana CB; Pallocca M; Fenton H; Sopwith W; Eden CV; Akre O; Auranen A; Bocquet F; Borges M; Calvo E; Corkett J; Di Cosimo S; Gentili N; Guérin J; Jor S; Kazda T; Kolar A; Kuschel T; Lostes MJ; Paratore C; Pedrazzoli P; Petrovic M; Raid J; Roche M; Schatz C; Thonnard J; Tonon G; Traverso A; Wolf A; et alii...

Erratum: Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers. in Applied clinical informatics / Appl Clin Inform. 2024 Aug;15(4):e1. doi: 10.1055/s-0044-1792139. Epub 2024 Nov 4.

2024
AOU San Luigi di Orbassano

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling. in BMC cancer / BMC Cancer. 2022 Nov 24;22(1):1212. doi: 10.1186/s12885-022-10296-x.

2022
AOU San Luigi di Orbassano

Caccialanza R; Cereda E; Agustoni F; Klersy C; Casirati A; Montagna E; Carnio S; Novello S; Milella M; Pilotto S; Trestini I; Buffoni L; Ferrari A; Pedrazzoli P;

Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? in Nutrition (Burbank, Los Angeles County, Calif.) / Nutrition. 2022 Jun;98:111637. doi: 10.1016/j.nut.2022.111637. Epub 2022 Mar 3.

2022
AOU San Luigi di Orbassano

Pilotto S; Agustoni F; Morelli AM; Lobascio F; Cereda E; Bironzo P; Trestini I; Milella M; Novello S; Pedrazzoli P; Caccialanza R;

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Scagliotti GV; Porcu L; Manegold C; Monica V; Wiest G; Irtelli L; Caffo O; Dickgreber NJ; Follador A; Pedrazzoli P; Bearz A; Griesinger F; Folprecht G; Schmid-Bindert G; Reck M; Chiari R; Gregorc V; Santo A; Morabito A; Schena M; Valmadre G; Borra G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Cauchi C; Colantonio I; Geissler M; Meyer A; et alii...

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Apr;33(4):454. doi: 10.1016/j.annonc.2022.01.005. Epub 2022 Jan 25.

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Porcu L; Manegold C; Scagliotti GV; Monica V; Wiest G; Irtelli L; Dickgreber NJ; Caffo O; Pedrazzoli P; Bearz A; Folprecht G; Griesinger F; Follador A; Chiari R; Reck M; Morabito A; Santo A; Schmid-Bindert G; Gregorc V; Schena M; Valmadre G; Borra G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Cauchi C; Colantonio I; Geissler M; Meyer A; et alii...